Interpret sodium through water balance, potassium through electrical risk, and calcium through its regulators. Practice safe correction and acid-base reasoning.
An electrolyte result asks two different questions. Is the patient in immediate danger, and what process produced the concentration? A seizure with profound hyponatremia needs treatment while the cause is investigated. A high potassium result needs assessment of electrical risk even when the ECG looks reassuring. Work on urgency and explanation together.
Sodium concentration describes water relative to solute
Serum sodium is a concentration, not an inventory of total body sodium. A person with heart failure can retain sodium, have edema, and still be hyponatremic because water retention is proportionally greater. Start by considering glucose and measured serum osmolality. True hypotonic hyponatremia generally has serum osmolality below 275 mOsm/kg. Hyperglycemia can cause hypertonic, translocational hyponatremia as extracellular glucose draws water out of cells. That is a real dilutional concentration change, not an analytical artifact. [1]
Pseudohyponatremia is different. Severe hypertriglyceridemia or hyperproteinemia can distort sodium measured with an indirect ion-selective electrode because of the assumed plasma water fraction. A direct electrode measurement, such as a suitable blood gas analyzer, avoids that dilution-related artifact. Do not give hypertonic saline to normalize an indirect result when direct sodium and tonicity are normal. Different analytical methods can also complicate comparisons across serial samples.
A glucose-corrected sodium estimates what the concentration might be after the glucose-related water shift resolves. If a problem explicitly uses 1.6 mmol/L per 100 mg/dL glucose above 100, sodium 126 at glucose 500 corrects to 132.4 mmol/L. That is still low under that assumption. Other coefficients, including 2.4, have experimental support, especially as hyperglycemia becomes marked, so specify the method and follow measured sodium, glucose, and tonicity during treatment rather than treating one estimate as exact. [18]
Interpret the urine after confirming hypotonicity, without delaying emergency care
First assess urine osmolality
Urine osmolality at or below 100 mOsm/kg
Water excretion is relatively unsuppressed. Consider large water intake and low dietary solute, including low-protein or beer-predominant intake.
Urine osmolality above 100 mOsm/kg
Antidiuresis is present. It may be appropriate for poor effective circulation or related to nausea, pain, cortisol deficiency, drugs, or SIAD.
If urine osmolality is above 100, assess urine sodium
Urine sodium at or below about 30 mmol/L
Often supports sodium conservation in low effective arterial volume, including true depletion or edematous heart or liver disease.
Urine sodium above about 30 mmol/L
Consider diuretics, renal salt loss, adrenal disease, or SIAD. Interpret with diet, kidney function, volume, and timing of treatment.
These thresholds organize evidence rather than create four definitive diagnoses. Recent diuretics and CKD reduce urine sodium specificity. During vomiting, bicarbonate in urine can carry sodium despite volume depletion; a low urine chloride may better support chloride depletion. Bedside volume assessment is useful but imperfect, so use history, weight, balance, examination, and urine measurements together. [1]
Try it here · Checkpoint 1 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 4
Show answer and explanations for case 4
A. Pseudohyponatremia from the indirect measurement method (Best answer)
The excess nonaqueous plasma fraction can distort the diluted assay while direct measurement reflects a normal sodium concentration.
B. Severe hypotonic SIAD requiring immediate hypertonic saline (Why this does not fit)
Normal direct sodium and tonicity do not support treating the indirect result as a hypotonic emergency.
C. Hyperglycemic translocational hyponatremia (Why this does not fit)
Glucose is normal, and the method-dependent discrepancy supports an artifact rather than a glucose-driven water shift.
D. Central diabetes insipidus (Why this does not fit)
DI typically causes water loss and potentially hypernatremia, not this isolated low indirect result.
Takeaway: Confirm the measurement problem before treating an apparent sodium deficit.
Separate emergency correction from the long-term sodium plan
Seizures, marked reduction in consciousness, or other severe neurological manifestations in a patient with hypotonic hyponatremia require prompt monitored hypertonic saline. Moderately severe symptoms, including attributable confusion, can also warrant urgent hypertonic treatment. The 2022 Society for Endocrinology guidance uses an initial 150 mL bolus of 3 percent saline over twenty minutes, with reassessment and repeat dosing according to symptoms and sodium response.
Other established protocols use different bolus volumes. Follow one monitored protocol rather than combining doses from several. The initial aim is a small rise sufficient to reduce cerebral edema, commonly about 4 to 6 mmol/L, not rapid normalization. [2]
Chronic or duration-unknown hyponatremia needs protection against osmotic demyelination. Risk is greater with very low initial sodium, alcohol use disorder, malnutrition, advanced liver disease, and hypokalemia. A high-risk patient should not exceed an 8 mmol/L rise in any twenty-four hours, usually aiming for 4 to 6 mmol/L. Count from the pretreatment sodium, including the initial emergency rise; symptom improvement does not restart the clock.
European guidance limits correction to 10 mmol/L in the first twenty-four hours and 8 in each subsequent day. These are ceilings, not treatment goals. Monitor sodium frequently during active correction, commonly every two to four hours according to severity and protocol, and watch urine output for sudden water diuresis. Potassium replacement also contributes to sodium correction. [1][19]
Correction can accelerate when a volume deficit is restored, a thiazide is stopped, cortisol is replaced, or nausea resolves. If sodium is rising excessively, stop the provoking correction strategy and obtain expert help with controlled desmopressin and electrolyte-free water, often intravenous dextrose solution, when indicated. Demyelination may present after an apparent initial recovery and may affect pontine or extrapontine structures. Early symptom improvement does not permit abandoning correction limits. [2]
After stabilization, treat the cause. Hypovolemic hyponatremia often needs isotonic volume replacement, followed by surveillance for water diuresis. Heart failure or cirrhotic hyponatremia requires management of the underlying low effective circulation and congestion. SIAD requires hypotonicity, inappropriate antidiuresis, a compatible sodium excretion pattern and apparent euvolemia, with relevant adrenal, thyroid, kidney, and medication explanations assessed. Small-cell lung cancer, pulmonary or CNS disease, SSRIs, and carbamazepine are familiar associations, but an association alone does not prove SIAD. [1]
Normal potassium does not exclude central cortisol deficiency. A normal TSH does not exclude central hypothyroidism, for which free T4 and pituitary context matter. After subarachnoid hemorrhage, SIAD and renal salt wasting can both produce concentrated sodium-rich urine. Objective negative balance, weight loss, and hypovolemia favor salt wasting and change treatment toward replacement rather than restriction. Do not assume a single natriuretic peptide mechanism has been established in every case. [14][15]
For stable chronic SIAD, address the trigger and individualize fluid restriction. Specialist options can include urea or selected drug strategies when restriction fails. EFFUSE-FLUID did not show better sodium correction from adding furosemide, with or without oral sodium chloride, to restriction and identified more adverse effects with furosemide. This does not prohibit every selected second-line use, but it defeats an automatic escalation ladder.
Tolvaptan requires careful selection and hospital initiation or reinitiation under SAMSCA labeling, with a thirty-day limit for this use and avoidance of underlying liver disease. It is not neurological rescue therapy. European hyponatremia guidance is more restrictive about vaptans than the US label, so the treatment context and applicable protocol matter. [3][20]
High sodium usually means insufficient water for the solute load
Hypernatremia may follow impaired access to water, gastrointestinal or insensible water losses, osmotic diuresis, or diabetes insipidus. Assess thirst, intake, urine volume, glucose, and urine concentration. Persistent polyuria with dilute urine despite hypernatremia suggests deficient vasopressin action. Central diabetes insipidus reflects hormone deficiency; nephrogenic diabetes insipidus reflects renal resistance, including lithium exposure. [23] Desmopressin response can help distinguish them in a supervised evaluation, but unsafe water deprivation is not required in an already hypernatremic, depleted patient.
If the circulation is compromised, restore intravascular volume with an appropriate isotonic fluid before relying on free-water replacement alone. Then replace the estimated water deficit and continuing losses using enteral water or a suitable intravenous strategy, with repeated sodium measurements. The cited 2018 endocrine guidance specifically addresses adults with established cranial DI. In that population, it advises no more than 10 mmol/L per twenty-four hours; for mild or absent symptoms it also limits the rate to 0.5 mmol/L per hour.
Applying a correction plan to other causes of adult hypernatremia requires the cause, duration and clinical response to be considered. Acute cases and adult outcome evidence require individualized interpretation; a formula is a starting estimate, not a substitute for the observed sodium trajectory. In known central DI, omitted desmopressin and inability to drink can cause rapid deterioration. [16]
Potassium care has three parallel tasks
Most body potassium is intracellular, so serum concentration can change through redistribution as well as gain or loss. Insulin and beta-2 stimulation promote cellular uptake. Kidney failure, impaired aldosterone action, tissue breakdown, and potassium-retaining drugs can raise serum potassium. Hemolysis during sampling can also cause a false result. Repeat a suspect sample promptly when the clinical picture allows, but do not delay treatment of a credible severe result or ECG toxicity merely to prove it is real.
Hyperkalemia treatment addresses different endpoints at the same time
Stabilize the myocardium
Intravenous calcium treats potassium-associated ECG toxicity. It does not lower the serum potassium concentration.
Shift potassium into cells
Insulin with glucose is a main treatment. A nebulized beta-2 agonist is an adjunct. Check glucose repeatedly because hypoglycemia can be delayed.
Eliminate potassium
Dialysis, appropriate urinary excretion, and selected gastrointestinal binders address body potassium. Temporary intracellular redistribution does not replace elimination.
Hyperkalemia can produce peaked T waves, conduction slowing, QRS widening, bradyarrhythmias, and cardiac arrest, but the ECG does not progress through reliable numerical stages. A normal tracing cannot rule out danger. The UK Kidney Association's July 2026 guideline treats potassium at or above 6.5 mmol/L as severe. Hemodialysis patients with severe hyperkalemia need urgent dialysis, with appropriate temporizing treatment if dialysis is delayed and IV calcium for toxic ECG changes even when dialysis is immediately available.
Do not impose a waiting period for an insulin response before arranging dialysis when elimination is already required. UKKA advises against routine IV bicarbonate for acute hyperkalemia; a separate indication for severe acidosis requires its own assessment, and a beta-2 agonist should not be the sole treatment of severe hyperkalemia. [5]
Use a local insulin-glucose protocol that accounts for baseline glucose and kidney function. Continue glucose monitoring for at least six hours under the UKKA approach and recheck potassium for response and rebound. Modern binders can have selected acute or chronic roles, but an oral binder does not replace immediate stabilization. Older sodium polystyrene sulfonate should not be presented as reliable stand-alone emergency rescue. Review RAAS inhibitors, MRAs, trimethoprim, supplements, potassium-containing salt substitutes, and ongoing tissue injury. A painful swollen muscle group, dark urine, and a high creatine kinase suggest rhabdomyolysis rather than a dietary explanation alone. [5]
Hypokalemia below 3.5 mmol/L can result from gastrointestinal loss, diuretics, renal tubular loss, mineralocorticoid excess, or redistribution. Weakness, flattened T waves, ST depression, and U waves can occur, without a fixed sequence. Severe deficiency around 2.5 mmol/L or lower, symptoms, or electrical instability calls for monitored replacement, often intravenous. Stable patients who can absorb medication generally receive oral potassium. Never give potassium as an undiluted IV push; concentration, access, rate, kidney function, and repeat measurements matter. [6]
Measure magnesium when hypokalemia persists. Magnesium depletion can reduce inhibition of renal ROMK potassium channels, permitting continued potassium secretion, particularly when distal sodium delivery and related transport support it. Correct magnesium concurrently with potassium rather than withholding urgently needed potassium until magnesium is normal. Severe magnesium deficiency can also impair PTH secretion and action, contributing to hypocalcemia. [7][10]
DKA is the classic reason a high initial serum potassium can conceal total body depletion. Osmotic losses and insulin deficiency coexist. Insulin treatment can then rapidly lower potassium. The 2024 consensus advises delaying insulin when potassium is below 3.5 mmol/L until replacement raises it above 3.5. Routine bicarbonate is not recommended in DKA; consideration is reserved for severe acidosis, generally pH below 7.0. Use these thresholds in the adult population addressed by the 2024 consensus. [4]
Try it here · Checkpoint 2 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 26
Show answer and explanations for case 26
A. Pseudohyperkalemia from sample hemolysis as the best explanation despite the extensive muscle injury and rising creatinine (Why this does not fit)
Sampling artifacts are possible, but the crush syndrome gives a credible physiological source requiring urgent assessment.
B. Release of intracellular potassium from injured muscle, potentially compounded by AKI (Best answer)
The tissue injury and enzyme pattern fit rhabdomyolysis and create a continuing potassium load.
C. Hypoaldosteronism as the primary explanation for the abrupt rise (Why this does not fit)
This may impair excretion, but the tissue-injury findings strongly support potassium release from damaged muscle.
D. Increased dietary potassium as the primary explanation (Why this does not fit)
Diet alone is a weaker fit than extensive muscle injury with possible associated AKI.
Takeaway: Identify ongoing potassium release as well as impaired elimination.
Read calcium with its regulators and its biologically active fraction
Total calcium includes albumin-bound calcium. Low albumin can lower the total value without lowering ionized calcium, and pH changes alter binding. When illness, albumin, or pH makes total calcium difficult to interpret, measure ionized calcium rather than treating a correction formula as definitive. Hypocalcemia can cause perioral tingling, tetany, seizures, and QT prolongation. A positive Chvostek sign is not diagnostic by itself; Trousseau-type carpal spasm is supportive but still requires biochemical assessment. Severe symptomatic hypocalcemia requires monitored IV calcium and treatment of the cause. [10]
Hypercalcemia can cause polyuria, dehydration, constipation, cognitive change, stones, and a shortened QT interval. Interpret PTH relative to the high calcium. PTH should be suppressed; a high or inappropriately normal result suggests a PTH-dependent process such as primary hyperparathyroidism. Suppressed PTH redirects the search toward malignancy, vitamin D-related causes, medications, and other processes. PTHrP secretion, osteolysis, and calcitriol excess are different malignancy mechanisms. Squamous histology makes PTHrP plausible, but the tumor label alone is not a hormone measurement. [9][11]
Familial hypocalciuric hypercalcemia can mimic mild primary hyperparathyroidism. A calcium-to-creatinine clearance ratio below 0.01 and a family history support FHH, but values overlap. CKD, thiazides, and other factors can lower urine calcium. Confirm the interpretation before recommending parathyroid surgery. In CKD, phosphate retention and reduced calcitriol contribute to secondary hyperparathyroidism. Calcium is variable, not inevitably low, and calcium and phosphate do not always behave as mathematical opposites. Assess serial calcium, phosphate, and PTH together. [25][11][12]
For severe malignancy-associated hypercalcemia above 14 mg/dL, use volume-appropriate hydration plus antiresorptive treatment, with calcitonin as a rapid short-term adjunct. For adults with malignancy-associated calcium above 14 mg/dL, the Endocrine Society conditionally suggests calcitonin with an IV bisphosphonate or denosumab, based on very low certainty evidence. Limit calcitonin to forty-eight to seventy-two hours because its effect wanes.
Persistent hypercalcemia four hours after a first dose does not itself establish tachyphylaxis. Do not wait several days to initiate longer-acting treatment in a severe presentation. Loops are reserved for fluid overload rather than routine forced calcium excretion; dialysis may be needed in selected refractory or fluid-limited emergencies. [8][9]
Phosphate deserves its own attention. Marked deficiency can impair muscle and respiratory function. During refeeding after prolonged poor intake, insulin-driven cellular uptake can lower phosphate, potassium, and magnesium while thiamine requirements increase. Identify risk before feeding, provide thiamine and appropriate nutrition planning, and monitor and replace deficits. Treating each low number without recognizing the shared nutritional trigger leaves the continuing problem unaddressed. [17]
Use acid-base status to explain the electrolyte pattern
Calculate the serum anion gap from the same sample as sodium minus chloride minus bicarbonate. Interpret against the laboratory range and albumin. Low albumin can conceal an increased-gap process by lowering the expected baseline gap. [24] Diarrhea often causes bicarbonate loss and normal-gap acidosis; a functioning kidney responds by increasing ammonium excretion. RTA and CKD can impair that response. Urine sodium plus potassium minus chloride is an indirect ammonium-related calculation only under suitable conditions, not the serum gap and not a direct acid measurement. [22]
Vomiting and loop or thiazide exposure often produce chloride-depleted metabolic alkalosis with potassium loss. Low urine chloride can support chloride-responsive disease after the immediate drug effect has waned, whereas recent diuresis may keep urine chloride high. Hypertension with hypokalemic alkalosis directs attention toward mineralocorticoid or ENaC-mediated sodium retention. Normal or low blood pressure with a similar renal salt-wasting pattern can fit Bartter or Gitelman physiology, depending on the transport site, magnesium and calcium findings. Normal potassium does not exclude primary aldosteronism. [13]
In respiratory acidosis, the kidney raises bicarbonate over time. A common teaching estimate is about 1 mmol/L per 10 mmHg PaCO2 increase acutely and roughly 3.5 to 4 chronically, but these are approximate rules. Prospective steady-state data found a larger average chronic response, near 4.8 per 10 mmHg up to a PaCO2 near 70. Use plausible ranges, clinical duration, and the whole blood gas before diagnosing an additional metabolic disorder from a small discrepancy. After rapid correction of chronic hypercapnia, retained bicarbonate can produce post-hypercapnic alkalosis. [27][21]
The final synthesis should identify the immediate hazard, the likely mechanism, the treatment that changes that mechanism, and the measurements needed to detect rebound or excessive correction. An improving concentration is useful evidence, but it does not replace assessment of perfusion, neurological status, rhythm, ongoing losses, and the underlying disease.
An increased serum gap prompts evaluation for unmeasured acids, including lactate, ketoacids, retained acids in kidney failure, and toxic exposures such as methanol or ethylene glycol. Salicylate poisoning can combine increased-gap acidosis with respiratory alkalosis. These are competing or concurrent processes, not interchangeable diagnoses, and a possible toxic exposure requires urgent assessment. [26]
Try it here · Checkpoint 3 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 27
Show answer and explanations for case 27
A. Vomiting as the only explanation (Why this does not fit)
Vomiting can cause alkalosis but does not best explain hypertension with autonomous aldosterone secretion.
B. Bartter syndrome (Why this does not fit)
Salt wasting usually produces normal or low blood pressure and increased renin, unlike the described pattern.
C. Primary aldosteronism (Best answer)
Aldosterone excess despite suppressed renin favors autonomous mineralocorticoid activity with renal potassium and acid loss.
D. Primary adrenal insufficiency (Why this does not fit)
Adrenal mineralocorticoid deficiency generally favors low blood pressure and potassium retention.
Takeaway: Combine blood pressure with renin and aldosterone when interpreting potassium-losing alkalosis.
A. Allow a further 8 mmol/L after the initial symptom-relieving rise (Why this does not fit)
The initial rise counts toward the same twenty-four-hour limit; the clock does not restart.
B. Aim for 4 to 6 mmol/L and do not exceed 8 mmol/L in any twenty-four hours (Best answer)
This patient has several high-risk features. Count the initial bolus-related rise and subsequent potassium replacement in the same correction trajectory; the clock does not restart when symptoms improve.
C. Aim for a 10 mmol/L increase during the first twenty-four hours (Why this does not fit)
That exceeds the ceiling used for this high-risk patient and is not an appropriate planned target.
D. Count only sodium infused and exclude potassium replacement (Why this does not fit)
Potassium replacement can increase serum sodium and contributes to the observed correction trajectory.
Takeaway: A correction ceiling is not a target, especially in high-risk chronic disease.
A. Start tolvaptan to control the emerging water diuresis (Why this does not fit)
Tolvaptan increases electrolyte-free water excretion and can accelerate rather than slow correction.
B. Stop saline and wait until the next day to recheck sodium (Why this does not fit)
A high-risk patient already beyond the daily ceiling needs urgent frequent reassessment and consideration of controlled relowering.
C. Continue the same saline regimen until the sodium reaches the normal range, even though the current correction rate is already excessive (Why this does not fit)
The excessive rate matters even if the final sodium remains low; normalizing it is not the immediate goal.
D. Stop the excessive correction strategy and urgently consider controlled desmopressin and electrolyte-free water (Best answer)
A new water diuresis can cause dangerous overcorrection; expert-guided prevention or reversal is time-sensitive.
Takeaway: Watch the urine trajectory as closely as the saline prescription.
A. Add both drugs because the trial demonstrated faster sodium correction and use the combination routinely despite the reported kidney and potassium adverse effects (Why this does not fit)
EFFUSE-FLUID did not establish an added sodium-correction benefit over restriction alone.
B. Choose tolvaptan because this trial proved its superiority (Why this does not fit)
Tolvaptan was not the intervention compared in EFFUSE-FLUID.
C. It is not an automatic next step; the trial found no added correction benefit and more furosemide-related adverse effects (Best answer)
The regimen may be considered selectively, but evidence and potassium and kidney risks should guide use.
D. Add the loop to reduce the risk of AKI and hypokalemia (Why this does not fit)
These adverse effects were more frequent with furosemide in the trial.
Takeaway: Select second-line SIAD therapy rather than following a fixed ladder.
A. Give only hypotonic IV fluid as the initial treatment of shock (Why this does not fit)
The immediate circulation deficit requires appropriate isotonic resuscitation before relying on free water alone.
B. Replace the entire calculated water deficit in the first hour after initial resuscitation, aiming to normalize the sodium concentration as rapidly as possible (Why this does not fit)
Rapid normalization ignores duration, ongoing losses and the need for a monitored correction plan.
C. Restore circulation with an appropriate isotonic fluid, then replace free water and ongoing losses with monitoring (Best answer)
Shock requires perfusion support before free-water correction becomes the main task.
D. Give desmopressin before assessing the polyuria mechanism (Why this does not fit)
Impaired water access does not by itself diagnose central DI or establish a desmopressin indication.
Takeaway: Perfusion and tonicity require related but distinct fluid decisions.
A. Give IV calcium as the sole potassium-lowering treatment (Why this does not fit)
Calcium does not reduce potassium concentration and does not substitute for elimination.
B. Arrange urgent dialysis; give appropriate temporizing treatment if dialysis is delayed (Best answer)
Potassium 6.8 mmol/L meets the severe threshold in a hemodialysis patient even with a normal ECG. ECG-directed calcium protects the heart but does not lower potassium.
C. Use an oral potassium binder alone until the next scheduled dialysis despite the severe potassium elevation (Why this does not fit)
This is insufficient for severe hyperkalemia in a patient who has missed dialysis.
D. Schedule the next routine dialysis because the tracing is normal (Why this does not fit)
A normal ECG does not make potassium 6.8 safe or remove the urgent dialysis indication.
Takeaway: A reassuring tracing does not neutralize a severe potassium result.
A. Hydration alone with antiresorptive treatment deferred for several days despite severe symptomatic hypercalcemia (Why this does not fit)
Severe symptomatic malignancy-associated hypercalcemia warrants timely calcium-directed treatment.
B. Scheduled high-dose furosemide before volume restoration (Why this does not fit)
Forced calciuresis can worsen depletion; loops are reserved for clinically important overload.
C. Hydration and calcitonin alone for two weeks (Why this does not fit)
Calcitonin is limited by tachyphylaxis and should not replace sustained antiresorptive treatment.
D. Volume-appropriate hydration plus antiresorptive therapy and short-term calcitonin (Best answer)
This adult severe malignancy-associated presentation supports hydration adapted to volume and kidney function, an antiresorptive, and the guideline's conditional short-term calcitonin adjunct based on very low certainty evidence. Limit calcitonin to 48 to 72 hours.
Takeaway: Combine rapid and sustained treatment components in severe malignancy-associated hypercalcemia.
A. Recommend parathyroid surgery from the clearance ratio alone (Why this does not fit)
The low ratio supports FHH, for which routine parathyroid surgery is generally inappropriate; assess context and confounders.
B. Confirm FHH solely from the low clearance ratio without further assessment of kidney function, medicines, family history, or overlap (Why this does not fit)
Clearance ratios overlap with primary hyperparathyroidism and are affected by kidney function, medicines and other factors.
C. Exclude FHH because the calcium elevation is mild (Why this does not fit)
Mild lifelong hypercalcemia and affected relatives are compatible with FHH.
D. FHH is supported, but confirm the interpretation and account for overlap and confounders (Best answer)
A low ratio and family history favor FHH, while CKD, thiazides and overlap with primary hyperparathyroidism limit an absolute cutoff.
Takeaway: Use the clearance ratio as evidence rather than a standalone verdict.
A. Severe primary metabolic acidosis (Why this does not fit)
The bicarbonate is increased rather than reduced, and the hypercapnic context supports a respiratory primary process.
B. The values are compatible with substantial chronic renal compensation (Best answer)
Chronic bicarbonate adaptation is greater than the acute response and varies; these coherent values do not require a second metabolic diagnosis solely from a rigid shortcut.
C. Pure acute respiratory acidosis with no time for renal adaptation (Why this does not fit)
The sizable bicarbonate increase is more consistent with chronic adaptation than the small immediate buffering response alone.
D. A blood gas proving normal ventilation because pH is near normal (Why this does not fit)
A near-normal pH does not negate a PaCO2 of 60 or the chronic ventilatory abnormality.
Takeaway: Compensation changes pH without erasing the primary respiratory disorder.
A. Serum gap 10; urine gap positive 35 mmol/L (Why this does not fit)
The serum arithmetic is correct, but this reverses the sign of the urine calculation.
B. Serum gap 10; urine gap negative 35 mmol/L (Best answer)
140 minus (114 plus 16) is 10; 25 plus 20 minus 80 is negative 35. In context, normal-gap acidosis with increased ammonium chloride excretion supports an intact response to gastrointestinal bicarbonate loss.
C. Serum gap 26; urine gap negative 35 mmol/L (Why this does not fit)
26 omits bicarbonate from the serum subtraction; the urine arithmetic alone is correct.
D. Serum gap 16; urine gap positive 35 mmol/L (Why this does not fit)
16 is the bicarbonate concentration rather than the serum gap, and the urine calculation also has the wrong sign.
Takeaway: Keep serum and urine compartments separate, then interpret each calculated gap in context.
